Embryonic Signal Drives Pancreatic Cancer and Offers a Way to Kill It

Geron Hires Stifel Nicolaus to Sell Stem Cell Assets, CEO Scarlett Says

Geron Corporation Appoints Graham Cooper as Chief Financial Officer

Geron Corporation Appoints Graham Cooper as Chief Financial Officer

Geron Corporation Appoints Graham Cooper as Chief Financial Officer

GERON INITIATES PHASE 2 TRIAL OF GRN1005 IN BRAIN METASTASES FROM LUNG CANCER

Researchers Unmask Proteins In Telomerase, A Substance That Enables Cancer

GERON INITIATES PHASE 2 TRIAL OF GRN1005 IN BRAIN METASTASES FROM BREAST CANCER

Targeting telomerase-expressing cancer cells

Cancer Cells' DNA Repair Disrupted to Increase Radiation Sensitivity

Stem Cells Traced To Heart

Stem Cells: Old vs. New

Where Does Geron’s Exit from Embryonic Stem Cells Leave the Field?

Human ES Cells Evolve in Culture

Economics, not science, thwarts embryonic stem cell therapy

CIRM is lining up buyers

Geron shuts down world's first stem-cell trial (Kierstead's hope for continuance)

Geron: Study Shows GRN1005 Shrunk Brain Tumors, Well-Tolerated

Geron To Focus on its Novel Cancer Programs

Form 8-K for GERON CORP